Response to: `Correspondence on `EULAR Recommendations for the Management of Psoriatic Arthritis with Pharmacological Therapies: 2019 Update' by Fallon \emphet Al
Domains
Life Sciences [q-bio]Origin | Publisher files allowed on an open archive |
---|---|
Licence |